Clinical Trials
12 trialsNCT06431633 2026-05-18
ARIAN
Fundación GECP
Phase 3 Recruiting
NCT04791839 2026-05-06
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
Washington University School of Medicine
Phase 2 Active not recruiting
NCT04736173 2026-05-01
ARC-10
Arcus Biosciences, Inc.
Phase 2 Active not recruiting
NCT05891171 2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1 Active not recruiting
NCT05633667 2026-03-17
VELOCITY-Lung
Gilead Sciences
Phase 2 Recruiting
NCT05502237 2026-01-30
STAR-121
Gilead Sciences
Phase 3 Active not recruiting
NCT06790706 2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2 Recruiting
NCT05676931 2025-10-02
EDGE-Lung
Gilead Sciences
Phase 2 Active not recruiting
NCT04772989 2025-08-28
ARC-12
Arcus Biosciences, Inc.
Phase 1 Completed
NCT04262856 2025-08-26
ARC-7
Arcus Biosciences, Inc.
Phase 2 Completed
NCT03846310 2024-12-09
ARC-4
Arcus Biosciences, Inc.
Phase 1 Completed
NCT03629756 2024-05-24
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
Arcus Biosciences, Inc.
Phase 1 Completed